The company exchanged $724 million in a pair of senior notes and floating rate private placement notes that represented 41 percent of its outstanding total notes and private placement notes. In exchange, the company took out $395 million in First Lien Senior Secured Term Loans that mature in 2025.
Envision said the move will help the company “continue its operations in the fight against COVID-19, as well as to protect its long-term ability to care for patients and communities once the crisis has passed.”
Envision is owned by private equity firm KKR & Co., which paid $5.57 billion for the company and acquired its debt for a total purchase price of $9.9 billion.
More articles on ASCs:
12 centers resuming elective surgeries or considering it
6 ASC supply chain considerations before reopening centers
Pandemic hit the ASC sector hard, but it’s also ripe for recovery: 6 updates from Moody’s
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
